back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2021-01-26 14:49 Tx date 2021-01-22 |
$VXL
Vaxil Bio Ltd. (formerly Emerge Resources Corp.) |
Kellen, Ari
4 - Director of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$63,500
+635,000 vol $0.10 each |
6,177,183 | |
| Filed 2021-01-26 14:48 Tx date 2021-01-22 |
$VXL
Vaxil Bio Ltd. (formerly Emerge Resources Corp.) |
Kellen, Ari
4 - Director of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-63,500
-635,000 vol $0.10 each |
557,183 | |
| Filed 2021-01-26 14:45 Tx date 2021-01-21 |
$VXL
Vaxil Bio Ltd. (formerly Emerge Resources Corp.) |
Kellen, Ari
4 - Director of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
$-135,000
-1,350,000 vol $0.10 each |
1,192,183 | |
| Filed 2021-01-21 10:59 Tx date 2021-01-17 |
$VXL
Vaxil Bio Ltd. (formerly Emerge Resources Corp.) |
Kellen, Ari
4 - Director of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
$-200,000
-2,000,000 vol $0.10 each |
2,542,183 | |
| Filed 2021-01-06 10:39 Tx date 2021-01-04 |
$VXL
Vaxil Bio Ltd. (formerly Emerge Resources Corp.) |
Kellen, Ari
4 - Director of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
$-100,000
-1,000,000 vol $0.10 each |
4,542,183 | |
| Filed 2020-11-26 09:46 Tx date 2020-11-23 |
$VXL
Vaxil Bio Ltd. (formerly Emerge Resources Corp.) |
Kellen, Ari
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+557,183 vol |
5,542,183 | |
| Filed 2020-11-26 09:45 Tx date 2020-11-23 |
$VXL
Vaxil Bio Ltd. (formerly Emerge Resources Corp.) |
Kellen, Ari
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$41,788
+557,183 vol $0.075 each |
5,542,183 | |
| Filed 2020-10-08 11:32 Tx date 2018-01-26 |
$VXL
Vaxil Bio Ltd. (formerly Emerge Resources Corp.) |
Kellen, Ari
4 - Director of Issuer
Direct Ownership
|
Warrants
53 - Grant of warrants
|
+4,985,000 vol |
4,985,000 | |
| Filed 2020-10-08 11:29 Tx date 2017-12-05 |
$VXL
Vaxil Bio Ltd. (formerly Emerge Resources Corp.) |
Kellen, Ari
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-10-08 11:28 Tx date 2018-01-26 |
$VXL
Vaxil Bio Ltd. (formerly Emerge Resources Corp.) |
Kellen, Ari
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$249,250
+4,985,000 vol $0.05 each |
4,985,000 | |
| Filed 2020-10-08 11:25 Tx date 2017-12-05 |
$VXL
Vaxil Bio Ltd. (formerly Emerge Resources Corp.) |
Kellen, Ari
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-12-12 Tx date 2016-12-05 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Kellen, Ari
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-358,776
-19,932 vol $18.00 each |
76,142 | |
| Filed 2016-12-12 Tx date 2016-12-05 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Kellen, Ari
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-38,441 vol |
104,700 | |
| Filed 2016-12-12 Tx date 2016-12-05 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Kellen, Ari
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$691,938
+38,441 vol $18.00 each |
96,074 | |
| Filed 2016-05-16 Tx date 2016-05-12 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Kellen, Ari
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$2,875,027
+115,324 vol $24.93 each |
143,141 | |
| Filed 2016-01-28 Tx date 2016-01-26 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Kellen, Ari
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$857,055
+9,632 vol $88.98 each |
60,950 | |
| Filed 2016-01-28 Tx date 2016-01-26 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Kellen, Ari
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
$-857,055.36
-9,632 vol $88.98 each |
27,817 | |
| Filed 2016-01-28 Tx date 2014-05-20 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Kellen, Ari
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
$29,468,250
+225,000 vol $130.97 each |
450,000 | |
| Filed 2016-01-28 Tx date 2014-05-20 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Kellen, Ari
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
$9,822,750
+75,000 vol $130.97 each |
||
| Filed 2016-01-28 Tx date 2014-01-09 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Kellen, Ari
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+225,000 vol |
225,000 | |
| Filed 2016-01-28 Tx date 2014-01-09 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Kellen, Ari
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+75,000 vol |
||
| Filed 2016-01-28 Tx date 2016-01-26 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Kellen, Ari
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-295,146.66
-3,317 vol $88.98 each |
57,633 |